TaiRx (ROCO:6580) Cash-to-Debt : 49.28 (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is TaiRx Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. TaiRx's cash to debt ratio for the quarter that ended in Dec. 2024 was 49.28.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, TaiRx could pay off its debt using the cash in hand for the quarter that ended in Dec. 2024.

The historical rank and industry rank for TaiRx's Cash-to-Debt or its related term are showing as below:

ROCO:6580' s Cash-to-Debt Range Over the Past 10 Years
Min: 23.19 Med: 172.64 Max: 26447.2
Current: 49.28

During the past 10 years, TaiRx's highest Cash to Debt Ratio was 26447.20. The lowest was 23.19. And the median was 172.64.

ROCO:6580's Cash-to-Debt is ranked better than
71.52% of 1482 companies
in the Biotechnology industry
Industry Median: 7.525 vs ROCO:6580: 49.28

TaiRx Cash-to-Debt Historical Data

The historical data trend for TaiRx's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

TaiRx Cash-to-Debt Chart

TaiRx Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash-to-Debt

Get a 7-Day Free Trial

120.29

224.98

23.19

53.73

49.28

TaiRx Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Cash-to-Debt	Get a 7-Day Free Trial															23.19	17.72	53.73	52.19	49.28

Competitive Comparison of TaiRx's Cash-to-Debt

For the Biotechnology subindustry, TaiRx's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TaiRx's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TaiRx's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where TaiRx's Cash-to-Debt falls into.

Save Embed

;

Save Embed

;

TaiRx Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

TaiRx's Cash to Debt Ratio for the fiscal year that ended in Dec. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	513.985	/	(4.676	+	5.755)
	=	49.27

TaiRx's Cash to Debt Ratio for the quarter that ended in Dec. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	513.985	/	(4.676	+	5.755)
	=	49.27

TaiRx (ROCO:6580) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

TaiRx Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of TaiRx's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

TaiRx Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiRx Inc (ROCO:6580) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 66, Sanchong Road, 1st Floor, 6th Floor, Nangang District, Taipei, TWN, 11502

Website

https://www.trx.com.tw

TaiRx Inc is a pharmaceutical company based in Taiwan. It develops new drugs and improves current standard treatments to promptly find cures for diseases and fulfill unmet medical needs. The company focuses on new drug development for Asia and other markets.

TaiRx Headlines

No Headlines